用于基因递送的脂质纳米颗粒。
Lipid nanoparticles for gene delivery.
作者信息
Zhao Yi, Huang Leaf
机构信息
Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
出版信息
Adv Genet. 2014;88:13-36. doi: 10.1016/B978-0-12-800148-6.00002-X.
Abstract
Nonviral vectors which offer a safer and versatile alternative to viral vectors have been developed to overcome problems caused by viral carriers. However, their transfection efficacy or level of expression is substantially lower than viral vectors. Among various nonviral gene vectors, lipid nanoparticles are an ideal platform for the incorporation of safety and efficacy into a single delivery system. In this chapter, we highlight current lipidic vectors that have been developed for gene therapy of tumors and other diseases. The pharmacokinetic, toxic behaviors and clinic trials of some successful lipids particles are also presented.
摘要
为克服病毒载体所带来的问题，已开发出比病毒载体更安全、用途更广泛的非病毒载体。然而，它们的转染效率或表达水平远低于病毒载体。在各种非病毒基因载体中，脂质纳米颗粒是将安全性和有效性整合到单一递送系统中的理想平台。在本章中，我们重点介绍了目前已开发用于肿瘤和其他疾病基因治疗的脂质载体。还介绍了一些成功的脂质颗粒的药代动力学、毒性行为和临床试验情况。
相似文献
1
Lipid nanoparticles for gene delivery.
Adv Genet. 2014;88:13-36. doi: 10.1016/B978-0-12-800148-6.00002-X.
2
Lipid-coated calcium phosphate nanoparticles for nonviral gene therapy.
Adv Genet. 2014;88:205-29. doi: 10.1016/B978-0-12-800148-6.00007-9.
3
Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration.
Adv Drug Deliv Rev. 2017 Jun 1;115:115-154. doi: 10.1016/j.addr.2017.07.021. Epub 2017 Aug 1.
4
Nanoparticles as nonviral gene delivery vectors.
IEEE Trans Nanobioscience. 2007 Dec;6(4):319-30. doi: 10.1109/tnb.2007.908996.
5
Lipid-based nanoparticles in the systemic delivery of siRNA.
Nanomedicine (Lond). 2014 Jan;9(1):105-20. doi: 10.2217/nnm.13.192.
6
Preparation of lipid:peptide:DNA (LPD) nanoparticles and their use for gene transfection.
Methods Mol Biol. 2012;906:329-36. doi: 10.1007/978-1-61779-953-2_27.
7
Nonviral vectors: we have come a long way.
Adv Genet. 2014;88:1-12. doi: 10.1016/B978-0-12-800148-6.00001-8.
8
Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy.
Expert Rev Mol Diagn. 2005 Nov;5(6):893-905. doi: 10.1586/14737159.5.6.893.
9
Recent advances in nonviral vectors for gene delivery.
Acc Chem Res. 2012 Jul 17;45(7):971-9. doi: 10.1021/ar200151m. Epub 2011 Aug 26.
10
Applications of lipid nanoparticles in gene therapy.
Eur J Pharm Biopharm. 2016 Dec;109:184-193. doi: 10.1016/j.ejpb.2016.10.016. Epub 2016 Oct 24.
引用本文的文献
1
Controlling CRISPR-Cas9 genome editing in human cells using a molecular glue degrader.
Mol Ther Nucleic Acids. 2025 Jul 21;36(3):102640. doi: 10.1016/j.omtn.2025.102640. eCollection 2025 Sep 9.
2
Engineering Nanoparticles and Bioscaffolds for Targeted microRNA Delivery in Cardiovascular Regeneration-A Comprehensive Review.
FASEB J. 2025 Jul 31;39(14):e70871. doi: 10.1096/fj.202501226RR.
3
Assessment of the Effects of Ionizing Radiation on Biologic Drugs: mAb Product Quality and Risk Evaluation for Global Shipping Logistics.
Pharm Res. 2025 May 16. doi: 10.1007/s11095-025-03867-7.
4
PEGylated Liposomes of Disulfiram and Paclitaxel: A Promising Chemotherapeutic Combination Against Chemoresistant Breast Cancer.
Pharmaceuticals (Basel). 2025 Mar 28;18(4):487. doi: 10.3390/ph18040487.
5
Lipid nanoparticles target neutrophils to reduce SARS-CoV-2-induced lung injury and inflammation.
J Control Release. 2025 Jun 10;382:113736. doi: 10.1016/j.jconrel.2025.113736. Epub 2025 Apr 18.
6
A new paradigm for cancer immunotherapy: targeting immunogenic cell death-related noncoding RNA.
Front Immunol. 2025 Jan 23;15:1498781. doi: 10.3389/fimmu.2024.1498781. eCollection 2024.
7
The role of nanoparticles in transforming plant genetic engineering: advancements, challenges and future prospects.
Funct Integr Genomics. 2025 Jan 22;25(1):23. doi: 10.1007/s10142-025-01528-x.
8
Polymeric Vehicles for Nucleic Acid Delivery: Enhancing the Therapeutic Efficacy and Cellular Uptake.
Recent Adv Drug Deliv Formul. 2024;18(4):276-293. doi: 10.2174/0126673878324536240805060143.
9
Placental Gene Therapy for Fetal Growth Restriction and Preeclampsia: Preclinical Studies and Prospects for Clinical Application.
J Clin Med. 2024 Sep 23;13(18):5647. doi: 10.3390/jcm13185647.
10
Exploring delivery systems for targeted nanotechnology-based gene therapy in the inner ear.
Ther Deliv. 2024;15(10):801-818. doi: 10.1080/20415990.2024.2389032. Epub 2024 Sep 26.
本文引用的文献
1
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity.
Nat Commun. 2014 Jun 27;5:4277. doi: 10.1038/ncomms5277.
2
Uptake and transfection efficiency of PEGylated cationic liposome-DNA complexes with and without RGD-tagging.
Biomaterials. 2014 Jun;35(18):4996-5005. doi: 10.1016/j.biomaterials.2014.03.007. Epub 2014 Mar 21.
3
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates.
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):3955-60. doi: 10.1073/pnas.1322937111. Epub 2014 Feb 10.
4
Delivery of therapeutic siRNA to the lung endothelium via novel Lipoplex formulation DACC.
Mol Ther. 2014 Apr;22(4):811-20. doi: 10.1038/mt.2013.291. Epub 2014 Jan 6.
5
Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles.
Biomaterials. 2014 Mar;35(9):3027-34. doi: 10.1016/j.biomaterials.2013.12.022. Epub 2014 Jan 2.
6
Advances in Lipid Nanoparticles for siRNA Delivery.
Pharmaceutics. 2013 Sep 18;5(3):498-507. doi: 10.3390/pharmaceutics5030498.
7
Gene-silencing potency of symmetric and asymmetric lipid-conjugated siRNAs and its correlation with dicer recognition.
Bioconjug Chem. 2013 Dec 18;24(12):2045-57. doi: 10.1021/bc400391n. Epub 2013 Dec 9.
8
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial.
Lancet. 2014 Jan 4;383(9911):60-68. doi: 10.1016/S0140-6736(13)61914-5. Epub 2013 Oct 3.
9
Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery.
Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):12881-6. doi: 10.1073/pnas.1306529110. Epub 2013 Jul 23.
10
Surfactant-free, lipo-polymersomes stabilized by iron oxide nanoparticles/polymer interlayer for synergistically targeted and magnetically guided gene delivery.
Adv Healthc Mater. 2014 Feb;3(2):273-82. doi: 10.1002/adhm.201300122. Epub 2013 Jul 18.
Zotero 插件